Clinical trial
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With…
NCT00003251 · University of Illinois at Chicago, Other · Unknown status
Key facts
| NCT number | NCT00003251 |
|---|---|
| Title | Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer |
| Official title | A Pilot Study of Amifostine and Concomitant Cisplatin, Paclitaxel and Radiotherapy in Previously Irradiated, Recurrent Head and Neck Cancer |
| Lead sponsor | University of Illinois at Chicago, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Drug/Agent Toxicity by Tissue/Organ, Head and Neck Cancer, Radiation Toxicity |
| Intervention type | Drug, Radiation |
| Interventions | amifostine trihydrate, cisplatin, paclitaxel, radiation therapy |
| Enrollment | 46 |
| Start date | Dec 1, 1997 |
| First posted | Aug 13, 2004 |
| Last update posted | Dec 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: